- Joined
- Aug 1, 2014
- Messages
- 26,719
- Reaction score
- 6,278
- Location
- California
- Gender
- Male
- Political Leaning
- Other
Goldman CEO Loyd Blankfein
Goldman Sachs analysts attempted to address a touchy subject for biotech companies, cures could be bad for business in the long run.
"Is curing patients a sustainable business model?" analysts ask in an April 10 report entitled "The Genome Revolution."
"The potential to deliver 'one shot cures' is one of the most attractive aspects of gene therapy, however, such treatments offer a very different outlook with regard to recurring revenue versus chronic therapies," analyst Salveen Richter wrote in the note to clients Tuesday. "While this proposition carries tremendous value for patients and society, it could represent a challenge for genome medicine developers looking for sustained cash flow. In the case of hepatitis C, curing existing patients also decreases the number of carriers able to transmit the virus to new patients. Where an incident pool remains stable (eg, in cancer) the potential for a cure poses less risk to the sustainability of a franchise."
https://www.cnbc.com/2018/04/11/goldman-asks-is-curing-patients-a-sustainable-business-model.html
I've bolded a very important part of the report, maybe the single biggest bombshell from this- Goldman is saying that by curing patients with Hepatitis C, these patients aren't available to infect other people with the disease, whereas cancer is a more profitable disease in the long run because it will occur in new patients regardless of whether anyone is cured of it.
So how does Goldman get away with treating deathly ill people as nothing more than potential cash bags? Well...
43 out of 50 Goldman Sachs lobbyists in 2016-2017 have previously held government jobs.
Elected Officials WHO OWN GOLDMAN SACHS SHARES
Carper, Tom (D-DE)
Cruz, Ted (R-TX)
Tammy (D-IL)
Frankel, Lois J (D-FL)
Lawrence, Brenda (D-MI)
Lowenthal, Alan (D-CA)
Perdue, David (R-GA)
Peters, Gary (D-MI)Polis
Jared (D-CO)
Roe Phil (R-TN)
Schneider, Brad (D-IL)
Schrader, Kurt (D-OR)
Trott, Dave (R-MI)
Walberg, Tim (R-MI)
Westerman, Bruce (R-AR)
Whitehouse, Sheldon (D-RI)
Top Recipients of Campaign Contributions from Goldman for 2016 Elections
•DNC Services Corp $649,323
•Republican National Cmte $378,245
• Clinton, Hillary $351,976
• Right To Rise PAC $290,250
• Right To Rise USA $260,017
•National Republican Congressional Cmte $246,300
• Rubio, Marco $229,675
•Bush, Jeb $203,550
• Portman, Rob $188,000
• National Republican Senatorial Cmte
Wake up America. You're politicians and your medical care are owned by Loyd Blankfein and the vultures at Goldman Sachs.
https://www.opensecrets.org/orgs/summary.php?id=D000000085&cycle=2016
Last edited: